Chicago, IL, United States of America

Xinyu Guan

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Indiana University, University of Illinois. Active years: 2023-2024.


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Xinyu Guan in Chicago, IL

Introduction:

Xinyu Guan, a talented inventor based in Chicago, IL, has made significant contributions to the field of healthcare with his groundbreaking inventions. With a keen focus on developing compounds for the treatment of diseases like pulmonary arterial hypertension (PAH), Xinyu Guan has earned recognition for his innovative work.

Latest Patents:

Xinyu Guan's latest patents revolve around nicotinamide phosphoribosyltransferase (NAMPT) inhibitors and their potential applications in treating PAH. These compounds, outlined in Formula (II) and their pharmaceutically acceptable salts, show promise in combating this debilitating disease.

Career Highlights:

Having secured two patents, Xinyu Guan has exemplified his expertise in the pharmaceutical industry. His dedication to discovering novel treatment options for PAH underscores his commitment to improving healthcare outcomes for patients worldwide.

Collaborations:

Xinyu Guan has collaborated with esteemed colleagues such as Tom G Driver and Roberto F Machado during his tenure at renowned institutions like Indiana University and the University of Illinois. These partnerships have fostered a dynamic environment for innovation and knowledge exchange in the field of pharmaceutical research.

Conclusion:

Inventor Xinyu Guan's inventive spirit and passion for advancing healthcare solutions shine through his patent portfolio and collaborative efforts. His work stands as a testament to the importance of innovation in addressing complex medical challenges, ultimately benefiting society as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…